PREMARKET ALERT: Novavax (NVAX)

Posted in General 
July 9th, 2009

Novavax Inc. (Nasdaq: NVAX) shares are up more than 10 percent with nearly 100,000 shares traded in the premarket after the company announced a joint venture in India with Cadila Pharmaceuticals, called CPL Biologicals. The joint venture will focus on vaccines, biological therapeutics and diagnostics. CPL Biologicals also expects to develop the pandemic H1N1 influenza vaccine candidate in India that Novavax is developing in the United States. — Mike Tarsala

Comments are closed

-->